Echosens
Francesca Braga has over 20 years of work experience in the healthcare industry. Francesca is currently serving as the Director of Global Product Management at Echosens since 2022. Prior to this, they worked at GE Healthcare for several roles spanning from 1999 to 2022. Some of the key positions they held at GE Healthcare include Global Product Manager for Mammography, Global Product Manager for Workflow solutions for mammography, Europe Product Manager for Computed Tomography, Program Manager for Digital Breast Tomosynthesis, Lead Program Integrator for Digital Mammography, Project Leader for Medical Application - Mammography, Medical Application System Engineer, and Safety and Regulatory Engineer. In these roles, Francesca demonstrated their expertise in product management, strategic planning, commercial activation, marketing, product launches, and regulatory affairs. Francesca had led large cross-functional teams and contributed to the introduction of innovative healthcare solutions in the global market.
Francesca Braga started their education journey in 1992 when they enrolled at Politecnico di Milano. Francesca pursued a degree in Nuclear Engineering and focused on the field of study of Nuclear Physics. Francesca completed their studies at Politecnico di Milano in 1998.
In addition to their studies at Politecnico di Milano, Francesca Braga also attended ENSTA Paris from 1994 to 1996. During their time at ENSTA Paris, they pursued a degree in Engineering. However, the specific field of study at ENSTA Paris is not mentioned in the provided information.
Echosens
1 followers
A pioneer in its field, Echosens significantly changed the practice of liver diagnosis with FibroScan®, the non-invasive gold standard solution for comprehensive management of liver health. FibroScan® is recognized worldwide as the reference for liver fibrosis and liver steatosis assessment with more than 4,200+ peer-reviewed publications and 180+ international guidelines recommendations. Echosens has made FibroScan® available in over 100+ countries enabling millions of liver examinations worldwide. We are working hand in hand with physicians, medical academic research, pharmaceutical companies for patient identification and monitoring in NAFLD/NASH. As patient education is a major issue, we have created the "myliverexam" website that provides information about the role of the liver and why it is vital to the global health.